Position in ACHV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,856,750
+$4,196,009 QoQ
Shares Held
743,760
+230.9% QoQ
Ownership
0.723%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 111 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ACHV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. ACHV ranks #168 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in ACHV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,856,750 | 743,760 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $660,741 | 224,742 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,142,497 | 229,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $691,251 | 219,445 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $487,809 | 215,845 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,078,664 | 403,995 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,467,120 | 416,796 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,768,559 | 373,114 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $593,482 | 126,273 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $449,230 | 98,732 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $420,173 | 101,984 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $339,515 | 78,957 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $381,869 | 73,578 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $216,954 | 31,905 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $40,287 | 16,444 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $54,265 | 16,444 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $81,539 | 16,709 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $129,439 | 17,099 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $132,368 | 17,014 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $147,151 | 17,312 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $153,522 | 17,096 | Shares | Defined | 2021-08-13 | |
| 2020-06-30 | $16,320 | 40,804 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,849 | 23,789 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||